Research output per year
Research output per year
- 33 results
Search results
-
2024
Case Series of Men with the Germline APC I1307K variant and Treatment-Emergent Neuroendocrine Prostate Cancer
Economides, M. P., Nakazawa, M., Lee, J. W., Li, X., Hollifield, L., Chambers, R., Sarfaty, M., Goldberg, J. D., Antonarakis, E. S. & Wise, D. R., Feb 2024, In: Clinical Genitourinary Cancer. 22, 1, p. e31-e37.e1 8 p.Research output: Contribution to journal › Article › peer-review
-
DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 Trial
Iyer, G., Tangen, C. M., Sarfaty, M., Regazzi, A. M., Lee, I. L., Fong, M., Choi, W., Dinney, C. P. N., Flaig, T. W., Thompson, I. M., Lerner, S. P., McConkey, D. J. & Rosenberg, J. E., 1 Nov 2024, In: JCO Precision Oncology. 8, e2400287.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Low Alanine Aminotransferase as a Marker for Sarcopenia and Frailty, Is Associated with Decreased Survival of Bladder Cancer Patients and Survivors—A Retrospective Data Analysis of 3075 Patients
Laufer, M., Perelman, M., Segal, G., Sarfaty, M. & Itelman, E., Jan 2024, In: Cancers. 16, 1, 174.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Low Serum Alanine Aminotransferase Blood Activity Is Associated with Shortened Survival of Renal Cell Cancer Patients and Survivors: Retrospective Analysis of 1830 Patients
Laufer, M., Sarfaty, M., Jacobi, E., Itelman, E., Segal, G. & Perelman, M., Oct 2024, In: Journal of Clinical Medicine. 13, 19, 5960.Research output: Contribution to journal › Article › peer-review
Open Access -
2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
Guercio, B. J., Sarfaty, M., Teo, M. Y., Ratna, N., Duzgol, C., Funt, S. A., Lee, C. H., Aggen, D. H., Regazzi, A. M., Chen, Z., Lattanzi, M., Al-Ahmadie, H. A., Brannon, A. R., Shah, R., Chu, C., Lenis, A. T., Pietzak, E., Bochner, B. H., Berger, M. F. & Solit, D. B. & 3 others, , 2023, In: Clinical Cancer Research. 29, 22, p. 4586-4595 10 p.Research output: Contribution to journal › Article › peer-review
Open Access25 Scopus citations -
Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis
Rouvinov, K., Levanon, E., Peer, A., Sarfaty, M., Sarid, D., Neiman, V., Grikshtas, E., Rosenbaum, E., Kushnir, I., Talmor, B., Friger, M., Zarbiv, Y., Gez, E., Dresler, H., Shalata, W., Meirovitz, A., Shrem, N. S., Yakobson, A., Mermershtain, W. & Keizman, D., 2023, In: Frontiers in Oncology. 13, 1151701.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Low Alanine Aminotransferase, as a Marker of Sarcopenia and Frailty, Is Associated with Shorter Survival Among Prostate Cancer Patients and Survivors. A Retrospective Cohort Analysis of 4064 Patients
Laufer, M., Perelman, M., Sarfaty, M., Itelman, E. & Segal, G., Sep 2023, In: European Urology Open Science. 55, p. 38-44 7 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Novel Genetic Subtypes of Urothelial Carcinoma with Differential Outcomes on Immune Checkpoint Blockade
Sarfaty, M., Golkaram, M., Funt, S. A., Al-Ahmadie, H., Kaplan, S., Song, F., Regazzi, A., Makarov, V., Kuo, F., Ostrovnaya, I., Seshan, V., Zhao, C., Greenbaum, B., Liu, L., Rosenberg, J. E. & Chan, T. A., 10 Jun 2023, In: Journal of Clinical Oncology. 41, 17, p. 3225-3235 11 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
2022
Immune-Related Thyroiditis as a Predictor for Survival in Metastatic Renal Cell Carcinoma
Sagie, S., Gadot, M., Levartovsky, M., Gantz Sorotsky, H., Berger, R., Sarfaty, M. & Percik, R., 1 Feb 2022, In: Cancers. 14, 4, 875.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
RCC Real-World Data: Prognostic Factors and Risk Stratification in the Immunotherapy Era
Sagie, S., Sarfaty, M., Levartovsky, M., Sorotsky, H. G., Berger, R., Percik, R. & Gadot, M., 1 Jul 2022, In: Cancers. 14, 13, 3127.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
2021
A phase II trial of durvalumab and tremelimumab in metastatic, non-urothelial carcinoma of the urinary tract
Sarfaty, M., Whiting, K., Teo, M. Y., Lee, C. H., Peters, V., Durocher, J., Regazzi, A. M., McCoy, A. S., Hettich, G., Jungbluth, A. A., Al-Ahmadie, H., Ostrovnaya, I., Chaim, J., Bajorin, D. F., Rosenberg, J. E., Iyer, G. & Funt, S. A., Feb 2021, In: Cancer Medicine. 10, 3, p. 1074-1083 10 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations -
Central nervous system metastases in breast cancer: the impact of age on patterns of development and outcome
Ben-Zion Berliner, M., Yerushalmi, R., Lavie, I., Benouaich-Amiel, A., Tsoref, D., Hendler, D., Goldvaser, H., Sarfaty, M., Rotem, O., Ulitsky, O., Siegal, T., Neiman, V. & Yust-Katz, S., Jan 2021, In: Breast Cancer Research and Treatment. 185, 2, p. 423-432 10 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 Pandemic
Sarfaty, M., Feldman, D. R., Morris, M. J., Motzer, R. J., Rathkopf, D. E., Regazzi, A. M., Iyer, G., Voss, M. H., Bajorin, D. F. & Rosenberg, J. E., Jun 2021, In: Clinical Genitourinary Cancer. 19, 3, p. e178-e183Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer
Mutai, R., Barkan, T., Moore, A., Sarfaty, M., Shochat, T., Yerushalmi, R., Stemmer, S. M. & Goldvaser, H., Dec 2021, In: Breast. 60, p. 62-69 8 p.Research output: Contribution to journal › Article › peer-review
Open Access114 Scopus citations -
Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study
Reinhorn, D., Kuchuk, I., Shochat, T., Nisenbaum, B., Sulkes, A., Hendler, D., Rotem, O., Tsoref, D., Olitzky, O., Goldvaser, H., Sarfaty, M., Neiman, V., Prus, J., Gottfried, M., Yust-Katz, S. & Yerushalmi, R., Jul 2021, In: Breast Cancer Research and Treatment. 188, 2, p. 379-387 9 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
The cost of enfortumab vedotin wastage due to vial size—a real-world analysis
Sarfaty, M., Moore, A., Regazzi, A. M., Mitchell, A. P. & Rosenberg, J. E., 1 Dec 2021, In: Cancers. 13, 23, 5977.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
2020
Next-generation sequencing in salivary gland carcinoma: Targetable alterations lead to a therapeutic advantage—Multicenter experience
Moore, A., Bar, Y., Maurice-Dror, C., Ospovat, I., Sarfaty, M., Korzets, Y., Goldvaser, H., Gordon, N., Billan, S., Gutfeld, O. & Popovtzer, A., 1 Apr 2020, In: Head and Neck. 42, 4, p. 599-607 9 p.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real-world early-stage breast cancer
Goldstein, D. A., Mayer, C., Shochat, T., Reinhorn, D., Moore, A., Sarfaty, M., Yerushalmi, R. & Goldvaser, H., 1 Jul 2020, In: Cancer Medicine. 9, 13, p. 4603-4612 10 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
2019
A Cost-Effectiveness Analysis of Nivolumab and Ipilimumab Versus Sunitinib in First-Line Intermediate- to Poor-Risk Advanced Renal Cell Carcinoma
Reinhorn, D., Sarfaty, M., Leshno, M., Moore, A., Neiman, V., Rosenbaum, E. & Goldstein, D. A., Mar 2019, In: Oncologist. 24, 3, p. 366-371 6 p.Research output: Contribution to journal › Article › peer-review
Open Access28 Scopus citations -
The Financial Impact of Fractionation Scheme and Treatment Planning Method for Rectal Cancer in the United States
Moore, A., Den, R. B., Gordon, N., Sarfaty, M., Kundel, Y., Brenner, B. & Goldstein, D. A., Sep 2019, In: Clinical Colorectal Cancer. 18, 3, p. 209-217 9 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United States
Moore, A., Stav, I., Den, R. B., Gordon, N., Sarfaty, M., Neiman, V., Rosenbaum, E. & Goldstein, D. A., 2019, In: Journal of Oncology. 2019, 8170428.Research output: Contribution to journal › Article › peer-review
Open Access27 Scopus citations -
2018
Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma
Sarfaty, M., Leshno, M., Gordon, N., Moore, A., Neiman, V., Rosenbaum, E. & Goldstein, D. A., Apr 2018, In: European Urology. 73, 4, p. 628-634 7 p.Research output: Contribution to journal › Article › peer-review
60 Scopus citations -
Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer
Sarfaty, M., Hall, P. S., Chan, K. K. W., Virik, K., Leshno, M., Gordon, N., Moore, A., Neiman, V., Rosenbaum, E. & Goldstein, D. A., Jul 2018, In: European Urology. 74, 1, p. 57-62 6 p.Research output: Contribution to journal › Article › peer-review
Open Access50 Scopus citations -
Early PET-CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective study
Moore, A., Ulitsky, O., Ben-Aharon, I., Perl, G., Kundel, Y., Sarfaty, M., Lewin, R., Domachevsky, L., Bernstine, H., Groshar, D., Wasserberg, N., Kashtan, H., Gordon, N., Sulkes, A. & Brenner, B., Nov 2018, In: Cancer Medicine. 7, 11, p. 5470-5477 8 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
2017
Esophageal cancer in Israel has unique clinico- pathological features: A retrospective study
Sarfaty, M., Lankry, E., Moore, A., Kurman, N., Purim, O., Kundel, Y., Ben-Aharon, I., Perl, G., Ulitsky, O., Gordon, N., Sulkes, A., Menasherov, N., Kashtan, H. & Brenner, B., 2017, In: Journal of Cancer. 8, 13, p. 2417-2423 7 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Not only for melanoma. Subcutaneous pseudoprogression in lung squamous-cell carcinoma treated with nivolumab: A case report
Sarfaty, M., Moore, A., Dudnik, E. & Peled, N., 2017, In: Medicine (United States). 96, 4, 5951.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations -
RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients
Sarfaty, M., Moore, A., Neiman, V., Dudnik, E., Ilouze, M., Gottfried, M., Katznelson, R., Nechushtan, H., Sorotsky, H. G., Paz, K., Katz, A., Saute, M., Wolner, M., Moskovitz, M., Miller, V., Elvin, J., Lipson, D., Ali, S., Gutman, L. S. & Dvir, A. & 2 others, , Jul 2017, In: Clinical Lung Cancer. 18, 4, p. e223-e232Research output: Contribution to journal › Article › peer-review
27 Scopus citations -
Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma
Moore, A., Cohen-Naftaly, M., Tobar, A., Kundel, Y., Benjaminov, O., Braun, M., Issachar, A., Mor, E., Sarfaty, M., Bragilovski, D., Hur, R. B., Gordon, N., Stemmer, S. M. & Allen, A. M., 19 Oct 2017, In: Radiation Oncology. 12, 1, 163.Research output: Contribution to journal › Article › peer-review
Open Access59 Scopus citations -
2016
A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer
Brenner, B., Sarfaty, M., Purim, O., Kundel, Y., Amit, L., Abramovich, A., Gonik, U. S., Idelevich, E., Gordon, N., Medalia, G. & Sulkes, A., Jul 2016, In: PLoS ONE. 11, 7, e0157548.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Cancer drug pricing and reimbursement: Lessons for the united states from around the world
Goldstein, D. A. & Sarfaty, M., Aug 2016, In: Oncologist. 21, 8, p. 907-909 3 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
Radiotherapy and sorafenib in the management of patients with hepatocellular carcinoma have led to improved survival: A single center experience
Moore, A., Cohen-Naftaly, M., Benjaminov, O., Braun, M., Issachar, A., Mor, E., Tovar, A., Sarfaty, M., Gordon, N. & Stemmer, S. M., 2016, In: Journal of Cancer. 7, 8, p. 883-889 7 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
2015
Metastatic Salivary Gland Tumors: A Single-Center Study Demonstrating the Feasibility and Potential Clinical Benefit of Molecular-Profiling-Guided Therapy
Popovtzer, A., Sarfaty, M., Limon, D., Marshack, G., Perlow, E., Dvir, A., Soussan-Gutman, L. & Stemmer, S. M., 2015, In: BioMed Research International. 2015, 614845.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
2013
Outcome of percutaneous endoscopic gastrostomy insertion in patients with amyotrophic lateral sclerosis in relation to respiratory dysfunction
Sarfaty, M., Nefussy, B., Gross, D., Shapira, Y., Vaisman, N. & Drory, V. E., Dec 2013, In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14, 7-8, p. 528-532 5 p.Research output: Contribution to journal › Article › peer-review
27 Scopus citations